PCA 50941

a 1,4-dihydropyridine derivative containing a 1,2-benzisothiazole-3-one-1,1-dioxide group; structure given in first source

Also Known As:

PCA-50941; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(3-oxo-1,2-benzisothiazol-2(3H)-yl)ethyl (tetrahydro-2H-pyran-2-yl)methyl ester, S,S-dioxide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - PCA 50941: 1
  - Pyridines: 88
    - Dihydropyridines: 214
      - PCA 50941: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - PCA 50941: 1

Related Diseases

1.	Seizures (Absence Seizure) 06/15/1998 - "Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice."

Related Drugs and Biologics

1.	Pentylenetetrazole (Metrazol)
2.	Nimodipine (Modus)
3.	Dihydropyridines
4.	Anticonvulsants (Antiepileptic Drugs)
5.	PCA 50922